TABLE 2.
Studies of gastrointestinal microbiota metabolites and their effects.
| Ref | Metabolites | Primary sources | Effects |
|---|---|---|---|
| Markowiak-Kopeć and Śliżewska, (2020); Serpa et al., (2010); Haveaar, (2011) | ScFAs (formic acid, acetic acid, propionic acid, butyric acid) | The Clostridium group of Firmicutes phylum, and Lactobacillus, Bifidobacterium, Eubacteriaceae, Fecal bacteria | Regulation of the pH value in the intestine; Promoting the absorption of water, sodium, calcium, magnesium and other substances; Inhibiting the multiplication and growth of pathogenic bacteria and the activity of intestinal inflammatory mediator; Maintaining the integrity of gap junctions in the intestine. |
| Alexandrov et al. (2020) | Lipid (cholesterol, LPS, peptidoglycan) | Bifidobacterium, Lactobacillus, Enterobacteriaceae and Clostridium | Regulation of the intestinal permeability and intestinal immunity; Disruption of the body’s immune system and induction of inflammatory responses. |
| Brown et al. (2019) | Lipid (sphingolipids) | Bacteroidetes and Prevotellaceae | Aggravating intestinal inflammation |
| Gao et al., (2019); Gao et al. (2020) | Indole-derived (tryptophan) | Clostridium sporogenes and Escherichia coli | Regulation of the brain-gut axis and protection against stress-induced damage in the gastrointestinal tract |